Business Context and Reporting Period
This Form 8-K Current Report was filed by Microvast Holdings, Inc. on June 27, 2022. The filing addresses corporate governance changes and a regulatory notice regarding Nasdaq listing compliance. The Company is an emerging growth company with common stock (MVST) and warrants (MVSTW) listed on The Nasdaq Global Select Market.
Key Financial Metrics
This filing does not contain financial performance data. There are no reported values for revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes
- Nasdaq Compliance Notice: On June 21, 2022, the Company received a notice from Nasdaq indicating non-compliance with Listing Rule 5605. The deficiency arose because the Audit Committee fell below the required minimum of three independent directors following the resignation of Mr. Craig Webster on April 14, 2022.
- Cure Period: Nasdaq granted a cure period to regain compliance by October 11, 2022. The notice has no immediate effect on the listing of the Company's securities.
- Board Composition Changes:
- Appointment: Yeelong Tan Balladon was appointed as a Class III director, effective July 1, 2022. She will serve on the Audit Committee, Nominating and Corporate Governance Committee, and as Chair of the Compensation Committee.
- Resignation: Craig Webster resigned from the Board effective July 1, 2022, in connection with his appointment as Chief Financial Officer. He had previously resigned from all committee roles upon becoming CFO.
- Compliance Resolution: The Board determined that Ms. Balladon is independent and qualified, expecting to regain compliance with Listing Rule 5605 on July 1, 2022.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding future business performance. The primary risk disclosed is the temporary non-compliance with Nasdaq listing standards regarding Audit Committee composition, which the Company expects to resolve immediately upon the new director's appointment.
Investor Verification Checklist
- Verify that Yeelong Tan Balladon's appointment as an independent director was effective July 1, 2022, restoring the Audit Committee to three members.
- Confirm that the Company's common stock and warrants remain listed on The Nasdaq Global Select Market without interruption.
- Review the Company's standard non-employee director compensation policy referenced in the 2021 Form 10-K for details on Ms. Balladon's compensation.
- Monitor subsequent filings to ensure the Company formally notified Nasdaq of the cure of the deficiency.